Author: Kieran Whitlock - Page 2

Switching from Warfarin to a DOAC: Side Effects and Safety Tips

Switching from Warfarin to a DOAC: Side Effects and Safety Tips

Switching from warfarin to a DOAC can reduce bleeding risks and eliminate frequent blood tests - but only if done correctly. Learn the critical timing rules, who should avoid it, and how to stay safe during the transition.

Diabetes Technology: CGMs, Smart Pens, and Apps That Help

Diabetes Technology: CGMs, Smart Pens, and Apps That Help

CGMs, smart insulin pens, and diabetes apps are transforming how people manage diabetes-offering real-time insights, predictive alerts, and better control. No more guessing. Just data-driven confidence.

GERD and Bisphosphonates: How to Prevent Esophageal Irritation

GERD and Bisphosphonates: How to Prevent Esophageal Irritation

Bisphosphonates like alendronate can cause serious esophageal irritation in people with GERD. Learn how to take them safely, recognize warning signs, and choose alternatives to avoid injury.

When to Call Poison Control vs. Emergency Services for Overdose

When to Call Poison Control vs. Emergency Services for Overdose

Learn when to call Poison Control versus 911 during an overdose. Key signs like unresponsiveness, seizures, or breathing trouble mean call 911. If someone is alert and you know what they took, call Poison Control first. Save time and lives with the right move.

Blockbuster Patent Expirations 2025 and Beyond: What’s Coming and How It Changes Your Medication Costs

Blockbuster Patent Expirations 2025 and Beyond: What’s Coming and How It Changes Your Medication Costs

Blockbuster drug patents are expiring between 2025 and 2030, with Entresto, Eliquis, and Keytruda leading the wave. This will slash drug prices by up to 90%, save billions in healthcare costs, and reshape how medications are prescribed and paid for.

5-HTP and SSRIs: Why Combining Them Can Be Dangerous

5-HTP and SSRIs: Why Combining Them Can Be Dangerous

Combining 5-HTP with SSRIs can cause serotonin syndrome-a potentially fatal condition. Learn why this supplement-drug interaction is dangerous, what the symptoms are, and what you should do instead.

Bioequivalence of Combination Products: Special Testing Challenges

Bioequivalence of Combination Products: Special Testing Challenges

Bioequivalence testing for combination products like FDCs, topical creams, and inhalers faces major scientific and regulatory hurdles that delay generic access and raise costs. Understanding the challenges reveals why affordable alternatives remain rare.

Manufacturer Reporting: What Every Company Must Know About Safety Obligations

Manufacturer Reporting: What Every Company Must Know About Safety Obligations

Manufacturers must report product safety issues to federal agencies like the FDA, CPSC, and NHTSA. Learn the deadlines, penalties, and real-world costs of compliance-and what happens when you miss them.

WHO Model Formulary: International Standards for Essential Generics

WHO Model Formulary: International Standards for Essential Generics

The WHO Model List of Essential Medicines sets global standards for affordable, high-quality generic drugs. Used by over 150 countries, it ensures life-saving treatments are available where they're needed most.

Patient Safety Goals in Medication Dispensing and Pharmacy Practice: What Hospitals Must Do Now

Patient Safety Goals in Medication Dispensing and Pharmacy Practice: What Hospitals Must Do Now

Medication errors cause thousands of preventable deaths each year. Learn the mandatory patient safety goals hospitals must follow, why traditional methods fail, and what real-world solutions are working in 2026.